3D Bioprinting of Living Human Tissues/Organs Market: Current Analysis and Forecast (2021-2027)

$3500$6860

Emphasis on Application (Research and Clinical), Technology (Inkjet, Extrusion, Laser-Assisted Bioprinting, and others), Material (Collagen, Gelatin, Alginate, Synthetic Macromolecules, Hyaluronic Acid, Generic Hydroge, and Others), Tissue Type (Generic Tissue/Organ, Renal, Skin, Bone, Liver, Lungs, Cardiac / Cardiovascular, Adipose Tissue, Cartilage, Ocular Tissue, Tumor Tissue, and Others), and Region/Country

Pages:

303

Table:

119

Figure:

183

Report ID:

UMHE21206

Geography:

Clear
  Get a Free Sample
SKU: UMHE21206 Category:
Report Description
Table of content
Research Methodology

Report Description

3D bioprinting has developed as an encouraging new approach for fabricating complex biological constructs in the field of tissue engineering and regenerative medicine. It aims to alleviate the hurdles of conventional tissue engineering methods by precise and controlled layer-by-layer assembly of biomaterials in a desired 3D pattern. As per the U.S. government information on Organ donation and Transplantation, 17 people die every year waiting for an organ transplant.

Moreover, As per the American Society of Transplantation, every ten minutes, someone is added to the national transplant waiting list in the American market. On average 20-25 people die each day while waiting for transplant surgery. Also, the limited number of organ donors in the industry would demand the 3D bioprinting of living human tissue in the forthcoming years as well. As per a survey by Organ Donor.Gov, 90% of U.S. adults support organ donation but only 60% are actually signed up as donors. only 3 in 1,000 people die in a way that allows for organ donation knowing the fact that one person can donate up to 8 lifesaving organs.

Moreover, demand for organ transplantation is increasing in the European region, but there are not enough organs available to meet the need. This shortage of organs is now the limiting factor in treating many patients with chronic organ failure and has led to high numbers of patients on waiting lists.  As per the Council of Europe, over 150,000 patients were registered on organ waiting lists in Europe in 2020. Moreover, On average every year, 41,000 patients receive a transplant, and 48,000 new patients are registered on waiting lists. That’s nearly six new patients added to a transplant waiting list every hour.

The Bioprinting Roadmap

Allevi, Aspect Biosystems, BioDan Group, Biolife 4D, Cellbrick GmbH, Cellink, Digiab, Microdrop Technologies, Microfab Technologies, etc., are some of the prominent players operating in the global 3D Bioprinting of Living Human Tissues/Organs market. Several M&As along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products.

Insights Presented in the Report

“Amongst application, Clinical segment holds the major share”

Based on the vector type, the market is fragmented into Research and Clinical. The clinical segment dominated the market with a share of 75.1% in 2019 and is expected to maintain its dominance during the forecast period owing to the emerging demand for organ transplantation such as bone, skin and heart valves, etc.,

“Amongst technology, extrusion segment dominated the market during the forecast period”

Based on technology type, the market is mainly fragmented into Inkjet, Extrusion, Laser-Assisted Bioprinting, and Others. In 2019, the extrusion segment accounted for a maximum market revenue share of 57.2% and is expected to remain dominant during the analyzed period.

“Amongst material, Collagen segment dominated the market during the forecast period”

Based on the material, the market is mainly disintegrated into Collagen, Gelatin, Alginate, Synthetic Macromolecules, Hyaluronic Acid, Generic Hydroge, and others. In 2019, the collagen segment accounted for a maximum market revenue share of 16.2% and is expected to remain dominant during the analyzed period owing to the expanded use of collagen biomaterial in various regenerative medicine and disease modeling applications (e.g., skin, bone, and cornea).

“Amongst tissue type, Generic Tissue/Organ segment holds the major share”

Based on tissue type, the market is bifurcated into Generic Tissue/Organ, Renal, Skin, Bone, Liver, Lungs, Cardiac/Cardiovascular, Adipose Tissue, Cartilage, Ocular Tissue, Tumor Tissue, and thers. In 2019, the Generic Tissue/Organ segment accounted for the maximum market share with 36.7% and is expected to be the leading segment of the 3D Bioprinting of Living Human Tissues/Organs market during the forecast period due to the rising number of patients for the organ transplant. As per a study,  a new patient is added to the list every ten minutes, and around 4,000 people in the US waiting for a transplant each year.

“North America represents one of the largest markets of 3D Bioprinting of Living Human Tissues/Organs market”

For a better understanding of the market dynamics of the 3D Bioprinting of Living Human Tissues/Organs market, a detailed analysis was conducted for different regions across the globe including North America (the U.S, Canada, and the Rest of North America), Europe (Germany, France, Spain, United Kingdom and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), Rest of World has been conducted. North America dominated the market and generated revenue of US$ 235.4 million in 2019 owing to the increasing incidence of chronic diseases and rising funding for R&D activities associated with 3D Bioprinting of Living Human Tissues/Organs.

Reasons to buy this report:

  • The study includes market sizing and forecasting analysis validated by authenticated key industry experts
  • The report presents a quick review of overall industry performance at one glance
  • The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments
  • Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry
  • The study comprehensively covers the market across different segments
  • Deep dive regional level analysis of the industry

Customization Options:

The 3D Bioprinting of Living Human Tissues/Organs Market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

You can also purchase parts of this report. Do you want to check out a section wise
price list?

  1.1Market Definitions
  1.2Objective of the Study
  1.3Limitation
  1.4Stake Holders
  1.5Currency Used in Report
  1.6Scope of the Global 3D Bioprinting of Living Human Tissues/Organs Market Study

 

  2.1Research Methodology for the Global 3D Bioprinting of Living Human Tissues/Organs Market
   2.1.1Main Objective of the Global 3D Bioprinting of Living Human Tissues/Organs Market

 

  7.1Inkjet 
  7.2Extrusion 
  7.3Laser Assisted Bioprinting
  7.4Others
  8.1Research 
  8.2Clinical
  9.1Collagen 
  9.2Gelatine 
  9.3Alginate 
  9.4Synthetic Macromolecules
  9.5Hyaluronic Acid
  9.6Generic Hydroge
  9.7Others

 

  10.1Generic Tissue / Organ
  10.2Renal 
  10.3Skin 
  10.4Bone 
  10.5Liver 
  10.6Lungs 
  10.7Cardiac / Cardiovascular
  10.8Adipose Tissue
  10.9Cartilage 
  10.10Ocular Tissue
  10.11Tumour Tissue
  10.12Others

 

  11.1Hospitals 
  11.2Research Organizations & Academic Institutes

 

  12.1North America 3D Bioprinting of Living Human Tissues/Organs Market 
   12.1.1United States
   12.1.2Canada
   12.1.3Rest of North America
  12.2Europe 3D Bioprinting of Living Human Tissues/Organs Market 
   12.2.1Germany
   12.2.2France
   12.2.3United Kingdom
   12.2.4Spain
   12.2.5Rest of Europe
  12.3Asia Pacific 3D Bioprinting of Living Human Tissues/Organs Market
   12.3.1China
   12.3.2Japan
   12.3.3India
   12.3.4Australia
   12.3.5Rest of Asia Pacific
  12.4Rest of the World 3D Bioprinting of Living Human Tissues/Organs Market 
  13.1Market Trends & Drivers
  13.2Market Challenges
  13.3Impact Analysis
  15.1Demand Side Analysis
  15.2Supply Side Analysis
   15.2.1Top Product Launches
   15.2.2Top Business Partnerships
   15.2.3Top Merger & Acquisitions
   15.2.4Top Business Expansions and Investments
  19.1Porter’s Five forces analysis
   19.1.1Bargaining power of Supplier
   19.1.2Bargaining power of Buyer
   19.1.3Industry Rivalry
   19.1.4Availability of Substitute
   19.1.5Threat of new Entrants
  20.1Allevi 
  20.2Aspect Biosystems
  20.3BioDan Group
  20.4Biolife4D 
  20.5Cellbricks GmbH
  20.6Cellink 
  20.7Digilab 
  20.8GeSiM 
  20.9Microdrop Technologies
  20.10MicroFab Technologies

Research Methodology

Analyzing the historical market, estimation of the current market, and forecasting the future market of the Global 3D Bioprinting of Living Human Tissues/Organs Market were the three major steps undertaken to create and analyze the adoption of 3D Bioprinting of Living Human Tissues/Organs for the different diseases across major regions globally. Exhaustive secondary research was conducted to collect the historical market numbers and estimate the current market size. Secondly, to validate these insights, numerous findings and assumptions were taken into consideration. Moreover, exhaustive primary interviews were also conducted, with industry experts across the value chain of the 3D Bioprinting of Living Human Tissues/Organs sector. Post assumption and validation of market numbers through primary interviews, we employed a top-down approach to forecast the complete market size. Thereafter, market breakdown and data triangulation methods were adopted to estimate and analyze the market size of segments and sub-segments the industry pertains to. Detailed methodology is explained below:

Analysis of Historical Market Size

Step 1: In-Depth Study of Secondary Sources:

Detailed secondary study was conducted to obtain the historical market size of the 3D Bioprinting of Living Human Tissues/Organs through company internal sources such as annual report & financial statements, performance presentations, press releases, etc., and external sources including journals, news & articles, government publications, competitor publications, sector reports, third-party database, and other credible publications.

Step 2: Market Segmentation:

After obtaining the historical market size of the 3D Bioprinting of Living Human Tissues/Organs market, we conducted a detailed secondary analysis to gather historical market insights and share for different segments & sub-segments for major regions. Major segments included in the report are application, technology, materials, tissue type, end-users. Further country-level analyses were conducted to evaluate the overall adoption of 3D Bioprinting of Living Human Tissues/Organs in that region.

Step 3: Factor Analysis:

After acquiring the historical market size of different segments and sub-segments, we conducted a detailed factor analysis to estimate the current market size of 3D Bioprinting of Living Human Tissues/Organs. Further, we conducted factor analysis using dependent and independent variables such as the surging demand for an organ transplant, rising investments in the research of 3D bioprinting of living human tissue. A thorough analysis was conducted for demand and supply-side scenarios considering top partnerships, merger and acquisition, business expansion, and product launches in the 3D Bioprinting of Living Human Tissues/Organs industry across the globe.

Current Market Size Estimate & Forecast

Current Market Sizing: Based on actionable insights from the above 3 steps, we arrived at the current market size, key players in the 3D Bioprinting of Living Human Tissues/Organs market, and market shares of the segments. All the required percentage shares split, and market breakdowns were determined using the above-mentioned secondary approach and were verified through primary interviews.

Estimation & Forecasting: For market estimation and forecast, weightage were assigned to different factors including drivers & trends, restraints, and opportunities available for the stakeholders. After analyzing these factors, relevant forecasting techniques i.e. bottom-up approach was applied to arrive at the market forecast about 2027 for different segments and subsegments across the major markets globally. The research methodology adopted to estimate the market size encompasses:

  • The industry’s market size, in terms of value (US$) and the adoption rate of 3D Bioprinting of Living Human Tissues/Organs across the major markets domestically
  • All percentage shares, splits, and breakdowns of market segments and sub-segments
  • Key players in the 3D Bioprinting of Living Human Tissues/Organs market in terms of services offered. Also, the growth strategies adopted by these players to compete in the fast-growing market

Market Size and Share Validation

Primary Research: In-depth interviews were conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, and Regional Head, Country Head, etc.) across major regions. Primary research findings were then summarized, and statistical analysis was performed to prove the stated hypothesis. Inputs from primary research were consolidated with secondary findings, hence turning information into actionable insights.

Split of Primary Participants in Different Regions

Market Engineering

Data triangulation technique was employed to complete the overall market estimation and to arrive at precise statistical numbers of each segment and sub-segment of the 3D Bioprinting of Living Human Tissues/Organs market. Data was split into several segments & sub-segments post studying various parameters and trends in the areas of research and clinical application, technology, materials, tissue type of the 3D Bioprinting of Living Human Tissues/Organs market.

Main Objective of the 3D Bioprinting of Living Human Tissues/Organs Market Study

The current & future market trends of 3D Bioprinting of Living Human Tissues/Organs were pinpointed in the study. Investors can gain strategic insights to base their discretion for investments from the qualitative and quantitative analysis performed in the study. Current and future market trends were determined the overall attractiveness of the market at a regional level, providing a platform for the industrial participant to exploit the untapped market to benefit as a first-mover advantage. Other quantitative goals of the studies include:

  • Analyze the current and forecast market size of 3D Bioprinting of Living Human Tissues/Organs in terms of value (US$). Also, analyze the current and forecast market size of different segments and sub-segments
  • Segments in the study include areas of application, technology, material, tissue type, and end-user sector
  • Define and analysis of the regulatory framework for the 3D Bioprinting of Living Human Tissues/Organs industry
  • Analyze the value chain involved with the presence of various intermediaries, along with analyzing customer and competitor behaviors of the industry
  • Analyze the current and forecast market size of the 3D Bioprinting of Living Human Tissues/Organs market for the major region
  • Major regions studied in the report include North America (the U.S and Canada), Europe (Germany, France, Spain, and United Kingdom), Asia-Pacific (China, Japan, Australia, and India), Rest of the World
  • Company profiles of the 3D Bioprinting of Living Human Tissues/Organs market and the growth strategies adopted by the market players to sustain in the fast-growing market
  • Deep dive regional level analysis of the industry